Mirion Technologies Announces Proposed Public Offering by Selling Stockholders
12 5월 2023 - 5:32AM
Business Wire
Mirion Technologies, Inc. (“Mirion,” “we” or the “company”)
(NYSE: MIR), a global provider of radiation detection, measurement,
analysis and monitoring solutions to the medical, nuclear, defense,
and research end markets, today announced the commencement of an
underwritten public offering of 7,000,000 shares of Mirion’s Class
A common stock by certain selling stockholders. Selling
stockholders participating in the offering consist of entities
affiliated with Charterhouse Capital Partners. Mirion will not sell
any securities in the proposed offering and will not receive any of
the proceeds from the sale of the shares being offered by the
selling stockholders, but Mirion will bear the costs associated
with the proposed offering, other than underwriting discounts and
commissions and certain other expenses. The offering is subject to
market and other conditions, and there can be no assurance as to
whether or when the offering may be completed or as to the actual
size or terms of the offering.
Citigroup is acting as the sole bookrunner for the offering.
The offering will be made pursuant to a shelf registration
statement, including a base prospectus, declared effective by the
Securities and Exchange Commission (the “SEC”) on November 28,
2022. Before you invest, you should read the prospectus in the
registration statement and the other documents Mirion has filed or
will file with the SEC for more complete information about Mirion
and this offering. The proposed offering is being made only by
means of an effective shelf registration statement, including a
base prospectus and final prospectus supplement, copies of which
may be obtained, when available, free of charge at the SEC’s
website at www.sec.gov. When available, copies of the prospectus
supplement and accompanying prospectus related to the offering may
also be obtained from Citigroup, c/o Broadridge Financial
Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel:
800-831-9146).
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy these securities, nor shall there
be any offer or sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to the registration or qualification under the
securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Words such as “anticipate,” “believe,” “continue,” “could,”
“estimate”, “expect”, “hope”, “intend”, “may”, “might”, “should”,
“would”, “will”, “understand” and similar words are intended to
identify forward looking statements. These forward-looking
statements include but are not limited to, statements regarding the
proposed public offering and the use of proceeds therefrom. Actual
results may differ materially from those described in the
forward-looking statements and will be affected by a variety of
risks and factors that are beyond our control including, without
limitation, market risks and uncertainties and the satisfaction of
customary closing conditions for an offering of securities, and
other risks set forth under the heading “Risk Factors” in Mirion’s
filings with the SEC from time to time, including our Annual Report
on Form 10-K, our Quarterly Reports on Form 10-Q and other periodic
reports filed or to be filed with the SEC.
You should not rely on these forward-looking statements, as
actual outcomes and results may differ materially from those
contemplated by these forward- looking statements as a result of
such risks and uncertainties. All forward-looking statements in
this press release are based on information available to us as of
the date hereof, and Mirion does not assume any obligation to
update the forward-looking statements provided to reflect events
that occur or circumstances that exist after the date on which they
were made.
About Mirion
Mirion Technologies is a leading provider of detection,
measurement, analysis and monitoring solutions to the nuclear,
defense, medical and research end markets. The organization aims to
harness its unrivaled knowledge of ionizing radiation for the
greater good of humanity. Headquartered in Atlanta (GA – USA),
Mirion employs approximately 2,700 people and operates in 12
countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230511005869/en/
For investor inquiries: Jerry Estes ir@mirion.com For
media inquiries: Matthew Maddox mmaddox@mirion.com
Mirion Technologies (NYSE:MIR)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Mirion Technologies (NYSE:MIR)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024